View in EDS HTML Full Text PDF Full Text

Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.

Saved in:
Bibliographic Details
Title: Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.
Authors: Otsuka K; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan., Isobe J; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan., Asai Y; Department of Systems Bioinformatics, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.; AI Systems Medicine Research and Training Center, Graduate School of Medicine, Yamaguchi University and Yamaguchi University Hospital, Yamaguchi, Japan., Nakano T; Department of Systems Bioinformatics, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan., Hattori K; Research Center for Drug Discovery and Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.; Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan., Ariyoshi T; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan., Yamashita T; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan., Motegi K; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan., Saito A; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan., Kohmoto M; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan., Hosonuma M; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan., Kuramasu A; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Baba Y; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Murayama M; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa University School of Medicine, Tokyo, Japan., Narikawa Y; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa University School of Medicine, Tokyo, Japan., Toyoda H; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan.; Department of Orthopedic Surgery, School of Medicine, Showa University, Tokyo, Japan., Funayama E; Division of Pharmacology, Department of Pharmacology, School of Pharmacy, Showa University, Tokyo, Japan., Tajima K; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Gastroenterological Surgery, Tokai University School of Medicine, Tokyo, Japan., Shida M; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Hirasawa Y; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Tsurui T; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Ariizumi H; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Ishiguro T; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Suzuki R; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Ohkuma R; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Kubota Y; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Sambe T; Division of Clinical Pharmacology, Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan., Tsuji M; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan., Wada S; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Kiuchi Y; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan., Kobayashi S; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Horiike A; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Goto S; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan., Murakami M; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan., Kim YG; Research Center for Drug Discovery and Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan., Tsunoda T; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Yoshimura K; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.; Pharmacological Research Center, Showa University, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Jan 27; Vol. 73 (2), pp. 23. Date of Electronic Publication: 2024 Jan 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38280026
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Otsuka+K%22">Otsuka K</searchLink>; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Isobe+J%22">Isobe J</searchLink>; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Asai+Y%22">Asai Y</searchLink>; Department of Systems Bioinformatics, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.; AI Systems Medicine Research and Training Center, Graduate School of Medicine, Yamaguchi University and Yamaguchi University Hospital, Yamaguchi, Japan.<br /><searchLink fieldCode="AU" term="%22Nakano+T%22">Nakano T</searchLink>; Department of Systems Bioinformatics, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.<br /><searchLink fieldCode="AU" term="%22Hattori+K%22">Hattori K</searchLink>; Research Center for Drug Discovery and Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.; Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ariyoshi+T%22">Ariyoshi T</searchLink>; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yamashita+T%22">Yamashita T</searchLink>; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Motegi+K%22">Motegi K</searchLink>; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Saito+A%22">Saito A</searchLink>; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kohmoto+M%22">Kohmoto M</searchLink>; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hosonuma+M%22">Hosonuma M</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kuramasu+A%22">Kuramasu A</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Baba+Y%22">Baba Y</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Murayama+M%22">Murayama M</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Narikawa+Y%22">Narikawa Y</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Toyoda+H%22">Toyoda H</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan.; Department of Orthopedic Surgery, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Funayama+E%22">Funayama E</searchLink>; Division of Pharmacology, Department of Pharmacology, School of Pharmacy, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tajima+K%22">Tajima K</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.; Department of Gastroenterological Surgery, Tokai University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shida+M%22">Shida M</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hirasawa+Y%22">Hirasawa Y</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsurui+T%22">Tsurui T</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ariizumi+H%22">Ariizumi H</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ishiguro+T%22">Ishiguro T</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+R%22">Suzuki R</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohkuma+R%22">Ohkuma R</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kubota+Y%22">Kubota Y</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sambe+T%22">Sambe T</searchLink>; Division of Clinical Pharmacology, Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuji+M%22">Tsuji M</searchLink>; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Wada+S%22">Wada S</searchLink>; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kiuchi+Y%22">Kiuchi Y</searchLink>; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kobayashi+S%22">Kobayashi S</searchLink>; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Horiike+A%22">Horiike A</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Goto+S%22">Goto S</searchLink>; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Murakami+M%22">Murakami M</searchLink>; Showa University Hospital Esophageal Cancer Center, Esophageal Surgery, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kim+YG%22">Kim YG</searchLink>; Research Center for Drug Discovery and Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsunoda+T%22">Tsunoda T</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimura+K%22">Yoshimura K</searchLink>; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.; Pharmacological Research Center, Showa University, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2024 Jan 27; Vol. 73 (2), pp. 23. <i>Date of Electronic Publication: </i>2024 Jan 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38280026
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-023-03608-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 23
    Titles:
      – TitleFull: Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Otsuka K
      – PersonEntity:
          Name:
            NameFull: Isobe J
      – PersonEntity:
          Name:
            NameFull: Asai Y
      – PersonEntity:
          Name:
            NameFull: Nakano T
      – PersonEntity:
          Name:
            NameFull: Hattori K
      – PersonEntity:
          Name:
            NameFull: Ariyoshi T
      – PersonEntity:
          Name:
            NameFull: Yamashita T
      – PersonEntity:
          Name:
            NameFull: Motegi K
      – PersonEntity:
          Name:
            NameFull: Saito A
      – PersonEntity:
          Name:
            NameFull: Kohmoto M
      – PersonEntity:
          Name:
            NameFull: Hosonuma M
      – PersonEntity:
          Name:
            NameFull: Kuramasu A
      – PersonEntity:
          Name:
            NameFull: Baba Y
      – PersonEntity:
          Name:
            NameFull: Murayama M
      – PersonEntity:
          Name:
            NameFull: Narikawa Y
      – PersonEntity:
          Name:
            NameFull: Toyoda H
      – PersonEntity:
          Name:
            NameFull: Funayama E
      – PersonEntity:
          Name:
            NameFull: Tajima K
      – PersonEntity:
          Name:
            NameFull: Shida M
      – PersonEntity:
          Name:
            NameFull: Hirasawa Y
      – PersonEntity:
          Name:
            NameFull: Tsurui T
      – PersonEntity:
          Name:
            NameFull: Ariizumi H
      – PersonEntity:
          Name:
            NameFull: Ishiguro T
      – PersonEntity:
          Name:
            NameFull: Suzuki R
      – PersonEntity:
          Name:
            NameFull: Ohkuma R
      – PersonEntity:
          Name:
            NameFull: Kubota Y
      – PersonEntity:
          Name:
            NameFull: Sambe T
      – PersonEntity:
          Name:
            NameFull: Tsuji M
      – PersonEntity:
          Name:
            NameFull: Wada S
      – PersonEntity:
          Name:
            NameFull: Kiuchi Y
      – PersonEntity:
          Name:
            NameFull: Kobayashi S
      – PersonEntity:
          Name:
            NameFull: Horiike A
      – PersonEntity:
          Name:
            NameFull: Goto S
      – PersonEntity:
          Name:
            NameFull: Murakami M
      – PersonEntity:
          Name:
            NameFull: Kim YG
      – PersonEntity:
          Name:
            NameFull: Tsunoda T
      – PersonEntity:
          Name:
            NameFull: Yoshimura K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 01
              Text: 2024 Jan 27
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 73
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1